4processed
Form 4 — Insider Transaction
Nurix Therapeutics, Inc.(NRIX)
Filing Date
June 25, 2026
Accepted
June 25, 2026
Accession No.
0001817160-26-000010
CIK
0001549595
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| Hansen Gwenn | Chief Scientific Officer | Other | 5.4K | $20 | — | 115.0K | Common Stock | Jun 25, 2026 |